This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Learn budgeting strategies focused on saving money through deliberate allocations, expense trimming, and goal-driven planning.
18,873 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Opendoor expands its cash-offer toolkit through a RealScout integration, framing it as opendoor’s ‘grand reopening’: ...
Ethereum is sliding again as on-chain data show a widening gap between futures bets and spot demand, with dip buyers ...
Lionsgate delivered stronger-than-expected results, and its stock jumped. This article breaks down the key factors be...
Lockup terms can shape the first days of a stock's life after an IPO. This guide explains standard practices, what an...
A mid-year 13F filing shows Sone Capital Management increasing its MarketAxess position. This article breaks down wha...
As ATS gears up for its Q4 2026 results, investors want clarity on revenue momentum, margins, and guidance. This arti...
Bitcoin briefly traded under $70,000 on June 2, 2026, as Mt. Gox moved a large tranche of BTC. Analysts say the move ...
Micron stock crashed today, sparking a flurry of questions about memory pricing and AI-driven demand. This guide brea...
In 2026, retirees confront six-figure required minimum distributions even after a broad tax bill. Analysts say the co...
A new AI-driven outlook on XRP is stirring market chatter as XRP hovers around $1.14. Analysts weigh whether the pred...
In 2026, memory-chip names Micron and Sandisk have surged past Nvidia, reshaping the AI stock landscape. This article...